This information was published on 2019-01-28T10:19:22 for IP Right Acceptance Published.
| Field | Value |
| (210) | 1948738 (IR 1417622) |
| (220) |
11 Jun 2018
|
| (300) |
US, 14 Dec 2017, 87721045
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions |
| (540) | HEMOXMOD |
| (550) | Word |
| (730) |
Global Blood Therapeutics, Inc.
|
Find out more about publications on the About page.